Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery

Area of Science:

• Pharmacology
• Drug Discovery
• Bioinformatics

Background:

• Therapeutic targets and their corresponding drugs are crucial for drug efficacy.
• The Therapeutic Target Database (TTD) serves as a comprehensive resource for this information.
• Previous versions of TTD have been instrumental in facilitating drug discovery and validation.

Purpose of the Study:

• To report major improvements and updates to the Therapeutic Target Database (TTD).
• To enhance the utility of TTD for target discovery, validation, and drug development.
• To provide a more comprehensive and updated resource for researchers in pharmacology and drug discovery.

Main Methods:

• Significant expansion of data content for targets and drugs.
• Integration of target validation information, including drug potency and genetic variation effects.
• Inclusion of quantitative structure-activity relationship (QSAR) models for active compounds.
• Addition of data on multi-target agents, drug combinations, and natural product-derived drugs.
• Cross-linking TTD entries with clinical trial information from ClinicalTrials.gov.

Main Results:

• TTD data content increased from 1894 targets and 5028 drugs to 2025 targets and 17,816 drugs.
• Target validation information added for 932 targets.
• 841 QSAR models for active compounds against 121 targets were incorporated.
• Data on 3681 multi-target agents, 116 drug combinations, and 1427 natural product-derived drugs were included.
• Cross-links to ClinicalTrials.gov provided for 770 clinical trial drugs.

Conclusions:

• The updated TTD provides a significantly enriched resource for the scientific community.
• These enhancements facilitate target discovery and validation, drug lead discovery and optimization.
• The database supports the development of advanced therapeutic strategies, including multi-target drugs and drug combinations.